
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1063 | 969 | 962 | 623 | 1031 | - |
Fund Return | 6.29% | -3.08% | -3.79% | -14.6% | 0.62% | - |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AXA SPDB Strategy Em Ind Balance | 708.18M | 0.71 | 0.70 | 10.38 | ||
AXA SPDB Consumption Upgrade Allo A | 586.72M | -3.21 | -4.81 | 6.82 | ||
AXA SPDB Consumption Upgrade Allo C | 586.72M | -3.20 | -5.00 | - | ||
AXA SPDB Growth flexible allocate | 575.6M | 3.38 | -9.41 | - | ||
AXA SPDB Value Growth Equity A | 521.31M | 1.99 | -11.33 | -0.40 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Zhongou Medical and Health Hybrid A | 32.09B | 0.38 | -16.27 | - | ||
Zhongou Medical and Health Hybrid C | 32.09B | 0.25 | -16.95 | - | ||
E Healthcare Secotor | 5.01B | 5.61 | 1.70 | 8.18 | ||
Fullgoal Precision Medical Mix Fund | 4.18B | 7.20 | -1.68 | - | ||
BOC Innovative Health Care Alloc | 3.01B | 15.67 | -1.43 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
THE EXPORT-IMPORT BANK OF CHINA BOND 2024 4 | - | 6.06 | - | - | |
Sinopep Allsino Bio Pharmaceutical Co | CNE1000051X5 | 5.17 | 53.56 | -0.33% | |
Mabwell Shanghai Bioscience | CNE100005RD2 | 4.74 | 17.65 | -2.16% | |
Shenyang Xingqi Pharma | CNE100002DV1 | 4.25 | 69.94 | -0.79% | |
CSPC Innovation | CNE100003K04 | 4.23 | 37.04 | -2.40% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Neutral |
Technical Indicators | Strong Buy | Strong Buy | Sell |
Summary | Strong Buy | Strong Buy | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review